Mutations of FLT3 are found in approximately 30% of newly diagnosed AML cases and occur as either ITDs (≈ 25%) or point mutations in the TKD (7–10%) [5, 9, 15, 16]. The gene discussed is FLT3; the disease is acute myeloid leukemia.